A 7‐year‐old female was born after a full‐term pregnancy. Enlarged ventricles (0.7–1.0 cm)
were observed during pregnancy without hydrocephalus. Large head circumference (39 cm),
hypotonia, facial hemangioma, patent foramen ovale, and hypothyroidism were found
after birth. The Bayley Scales of Infant and Toddler Development, Second Edition (BSID‐II),
at about 11 months of age revealed a motor development index <50, the development
level equivalent to a 6‐month‐old infant. The cognitive development index was 64,
equivalent to a 7‐month‐old infant. Head magnetic resonance imaging (MRI) suggested
bilateral white matter dysplasia and ventriculomegaly (Supplement Fig. S1A–D). Chromosome
karyotype analysis, copy number variations, and screening of congenital metabolic
disorders showed no abnormalities. When the child was 3 years old, generalized tonic‐clonic
seizures occurred. Video electroencephalogram (VEEG) revealed mild background slowing
(Supplement Fig. S1F, G). Her seizures were effectively controlled by levetiracetam,
and there were no seizures for 4 years. Two days before admission, her epilepsy reemerged.
An emergency blood glucose test revealed a blood glucose level of 1.3 mmol/L but returned
to normal levels after receiving glucose supplementation. Physical examination showed
a height of 114 cm (1 SD–2 SD), a weight of 21.5 kg (P25), and a head circumference
of 58.5 cm (>3 SD). She displayed specific abnormal facial features of macrocephaly,
high forehead, low nose bridge, inverted nostril, thick lips, and a thin face. Additionally,
her facial and physical features act asymmetrically, left limbs were smaller on the
left than the right side, head deviation to the left, torticollis, right‐eye strabismus,
short and thick fingers, flat feet, soft soles, and deformed feet (obvious on right
foot: middle toe bent inward, right fourth toe short, parallel to the fifth toe) (Supplement
Fig. S2A). The sternum is slightly valgus with mild hypotonia and hypertrichosis.
Interictal arterial spin labeling MRI (Supplement Fig. S1E) displayed relative hyperperfusion
in multiple areas of the left brain and left cerebellar. Repeated VEEG showed no obvious
abnormality.
A de novo variant in SETD1A (SET domain‐containing protein 1A) was detected [NM_014712.3:
exon8: c.2120_2121insA (p.Gly708Argfs*117)] caused by an insertion between 708th and
709th amino acid resulting in a truncated protein via early termination. Sanger sequencing
confirmed the variant in her family (Supplement Fig. S2B). The variant was not detected
in public databases and classified as pathogenic according to the American College
of Medical Genetics and Genomics guidelines (Supplement Table S1). Other pathogenic
variants of genes known to be associated with development, epilepsy, or intellectual
disability were not found in the proband.
According to the clinical manifestations, SETD1A gene mutation, and previous literature
reports, the girl was diagnosed with SETD1A‐related neurodevelopmental disorder with
dysmorphic facies. She started rehabilitation training at 1 year old, and her language
development was fair. The patient was followed up with for 6 months. Slightly uncoordinated
movement and posture as well as poor balance were observed. However, her cognitive
level continued to improve (Wechsler Intelligence Scale for Children [WISC] score
of 65). Currently, she is enrolled in kindergarten and her verbal memory is good.
She can communicate normally with slightly slower reaction times and poor logical
thinking. Recently, there was a short attention span and poor control of urine and
feces, but no feeding difficulties.
SETD1A is a member of the COMPASS (complex proteins associated with Set1) family of
proteins, all of which have H3K4 methyltransferase activity and are closely related
to neural development. SETD1A has been identified as a risk gene for schizophrenia,
and individuals with SETD1A variants may define a new subgroup of schizophrenia, often
associated with obsessive‐compulsive disorder.
1
Here, we described a proband with a de novo variant in SETD1A [NM_014712.3:exon8:
c.2120_2121insA (p.Gly708Argfs*117)] identified by whole‐exome sequencing. The main
manifestations of the proband were moderate global developmental delay, epilepsy,
hypotonia, short stature, special facial features, hemangioma, toe deformity, white
matter dysplasia, and ventricular dilation. Several studies have shown that individuals
with SETD1A variants may have unique characteristics, including epilepsy, general
developmental delay, and minor facial deformities (Table 1).
2
,
3
,
4
Table 1
Analysis of pathogenicity of variants in SETD1A
Phenotype
Overall
Truncating
Splice
Missense
Developmental retardation/mental retardation
100% (26 of 26)
100% (4 of 4)
100% (3/3)
100% (4/4)
Mental/behavior abnormalities
75% (18 of 24)
75% (3 of 4)
67% (2/3)
N
Facial deformity
42% (11 of 26)
75% (3 of 4)
67% (2/3)
N
Hypotonia
42% (11 of 26)
25% (1 of 4)
33% (1/3)
N
Epilepsy
38% (10 of 26)
50% (2 of 4)
N
100% (4/4)
Musculoskeletal abnormalities
32% (8 of 25)
25% (1 of 4)
N
N
Short stature
29% (7 of 24)
50% (2 of 4)
N
N
Hemangioma
15% (4 of 26)
50% (2 of 4)
67% (2/3)
N
Digit deformity
15% (4 of 26)
25% (1 of 4)
N
N
Head and neck deflection
12% (3 of 26)
25% (1 of 4)
N
N
Skeleton deformity
12% (3 of 26)
25% (1 of 4)
N
N
Macrocephaly*
4% (our case)
25% (1 of 4)
N
N
Facial and limb asymmetry*
4% (our case)
25% (1 of 4)
N
N
Stubby fingers*
4% (our case)
25% (1 of 4)
N
N
Hypertrichosis*
4% (our case)
25% (1 of 4)
N
N
#Kummeling et al summarized 15 children with SETD1A variants, but the corresponding
relationship between genotype and phenotype of each patient was not shown in his literature.
Therefore, mutation information does not include these 15 patients. #Our case contains
all of these phenotypic features.
*
These novel phenotypes were exclusively in our case.
Compared with previous reports, our case showed novel phenotypes such as macrocephaly,
hypertrichosis, stubby fingers, and unique face and toe deformities, namely, the facial
features, trunk, and limbs on the left side were relatively smaller than that on the
right. In addition, our patient had no obvious speech development disorder or behavioral
abnormality. Levetiracetam is effective in the treatment of seizures in our case.
In addition, there was another report that showed phenobarbital to improve SETD1A‐related
epilepsy.
4
This case enriches our understanding of SETD1A‐related neurodevelopmental disorders,
expanding the phenotype and genotype spectrum. Through literature review, we also
found that the truncating variants were more severe in clinical phenotypes, most of
which were accompanied by mental and behavioral disorders, facial deformities, and
short stature. This case provides valuable information for clinical diagnosis and
genetic counseling.
Disclosure statement
The authors have no competing interests to declare. Jia Zhang and Qiuji Tao contributed
equally to this work.
Ethics approval and consent to participate
The ethics committee of West China Second University Hospital judged that there was
no need to review this case.
Consent for publication
Written informed consent was obtained from her parents for the publication of this
case report.
Availability of data and materials
All data generated or analyzed during this study are included in this published article.
Supporting information
Figure S1. Head magnetic resonance imaging suggested bilateral white matter dysplasia
and ventriculomegaly (Fig. 1A, 1B, 1C, 1D). Video electroencephalography revealed
mild background slowing (Fig. 1F, 1G)
Click here for additional data file.
Figure S2. The patient's facial and physical features act asymmetrically, left limbs
smaller on the left than the right side, head deviation to the left, torticollis,
right‐eye strabismus, short and thick fingers, flat feet, soft soles, and deformed
feet (Fig. 2A). Pedigree and Sanger sequencing of the family confirmed the variant
in her family (Fig. 2B).
Click here for additional data file.
Table S1. Phenotype related to variant type.
Click here for additional data file.